Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Dahmke, Indra N ^a   Backes, Christina ^a   Rudzitis Auth, Jeannette ^a   Laschke, Matthias W ^a   Leidinger, Petra ^a   Menger, Michael D ^a   Meese, Eckart ^a   Mahlknecht, Ulrich ^a,b  

^a SAARLAND UNIVERSITY   (Germany)

^b St Lukas Klinik gGmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYCLINE; MICRORNA; MMU MICRORNA 205 5P; PROTEIN BCL 2; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELL STRAIN B78H1; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIETARY INTAKE; DOWN REGULATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; IN VITRO STUDY; INTRACELLULAR SIGNALING; MALE; MELANOMA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN PROCESSING; PROTEOGLYCAN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VASCULARIZATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CURCUMIN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MICE; MICE, INBRED C57BL; MICRORNAS; SOFTWARE;

EID: 84892520331     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081122     Document Type: Article

References (50)

1. Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379.
2. Chitwood DH, Timmermans MC (2010) Small RNAs are on the move. Nature 467: 415-419.
3. Taby R, Issa JP (2010) Cancer epigenetics. CA Cancer J Clin 60: 376-392.
4. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, et al. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 102: 13944-13949.
5. Litz J, Krystal GW (2006) Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells. Mol Cancer Ther 5: 1415-1422.
6. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC (2007) Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 100: 1164-1173.
7. Friedman JM, Jones PA (2009) MicroRNAs: critical mediators of differentiation, development and disease. Swiss Med Wkly 139: 466-472.
8. Poliseno L, Haimovic A, Segura MF, Hanniford D, Christos PJ, et al. (2012) Histology-specific microRNA alterations in melanoma. J Invest Dermatol 132: 1860-1868.
9. Fichtlscherer S, Zeiher AM, Dimmeler S (2011) Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31: 2383-2390.
10. Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, et al. (2011) Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 8: 506-516.
11. Izzotti A, Cartiglia C, Steele VE, De Flora S (2012) MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis. Mutat Res 751: 287-303.
12. Ohuchida K, Mizumoto K, Kayashima T, Fujita H, Moriyama T, et al. (2011) MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer. Ann Surg Oncol 18: 2381-2387.
13. Izzotti A, Larghero P, Cartiglia C, Longobardi M, Pfeffer U, et al. (2010) Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis 31: 894-901.
14. Jensen JD, Wing GJ, Dellavalle RP (2010) Nutrition and melanoma prevention. Clin Dermatol 28: 644-649.
15. Singh M, Singh N (2009) Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Mol Cell Biochem 325: 107-119.
16. Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269: 199-225.
17. Okunieff P, Xu J, Hu D, Liu W, Zhang L, et al. (2006) Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys 65: 890-898.
18. Phillips JM, Clark C, Herman-Ferdinandez L, Moore-Medlin T, Rong X, et al. (2011) Curcumin inhibits skin squamous cell carcinoma tumor growth in vivo. Otolaryngol Head Neck Surg 145: 58-63.
19. Limtrakul P, Lipigorngoson S, Namwong O, Apisariyakul A, Dunn FW (1997) Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett 116: 197-203.
20. Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, et al. (2011) Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) 4: 354-364.
21. Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, et al. (2011) A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol 68: 157-164.
22. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, et al. (2008) Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14: 4491-4499.
23. Bayet-Robert M, Kwiatkowski F, Leheurteur M, Gachon F, Planchat E, et al. (2010) Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther 9: 8-14.
24. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, et al. (2008) Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7: 464-473.
25. Yang J, Cao Y, Sun J, Zhang Y (2010) Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Med Oncol 27: 1114-1118.
26. Zhang J, Du Y, Wu C, Ren X, Ti X, et al. (2010) Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186*signaling pathway. Oncol Rep 24: 1217-1223.
27. Mudduluru G, George-William JN, Muppala S, Asangani IA, Kumarswamy R, et al. (2011) Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep 31: 185-197.
28. Bao B, Ali S, Banerjee S, Wang Z, Logna F, et al. (2012) Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res 72: 335-345.
29. Bao B, Ali S, Kong D, Sarkar SH, Wang Z, et al. (2011) Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. PLoS One 6: e17850.
30. Newcomb EW, Silverstein SC, Silagi S (1978) Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response. J Cell Physiol 95: 169-177.
31. Lollini PL, De Giovanni C, Del Re B, Nicoletti G, Prodi G, et al. (1987) Interferon-mediated enhancement of metastasis. Are MHC antigens involved? Clin Exp Metastasis 5: 277-287.
32. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
33. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002 30: 207-210.
34. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Statist Soc B 57: 289-300.
35. Backes C, Keller A, Kuentzer J, Kneissl B, Comtesse N, et al. (2007) GeneTrail-advanced gene set enrichment analysis. Nucleic Acids Res 35: W186-192.
36. Tanabe M, Kanehisa M (2012) Using the KEGG database resource. Curr Protoc Bioinformatics Chapter 1: Unit1 12.
37. Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, et al. (2013) Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Cell Tissue Res 351: 85-98.
38. Xu Y, Brenn T, Brown ER, Doherty V, Melton DW (2012) Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br J Cancer 106: 553-561.
39. Leyon PV, Kuttan G (2003) Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J Exp Clin Cancer Res 22: 77-83.
40. Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 94: 883-893.
41. Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, et al. (2008) Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol 23: 601-607.
42. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR- 200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601.
43. Greene SB, Gunaratne PH, Hammond SM, Rosen JM (2010) A putative role for microRNA-205 in mammary epithelial cell progenitors. J Cell Sci 123: 606-618.
44. Zhang X, Yan Z, Zhang J, Gong L, Li W, et al. (2011) Combination of hsa-miR- 375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol 22: 2257-2266.
45. Li BL, Lu C, Lu W, Yang TT, Qu J, et al. (2013) miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer. Med Oncol 30: 484.
46. Mazar J, DeYoung K, Khaitan D, Meister E, Almodovar A, et al. (2010) The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One 5: e13779.
47. Subramaniam D, Ponnurangam S, Ramamoorthy P, Standing D, Battafarano RJ, et al. (2012) Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One 7: e30590.
48. Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, et al. (2010) Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res 70: 3606-3617.
49. Dar AA, Majid S, de Semir D, Nosrati M, Bezrookove V, et al. (2011) miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein. J Biol Chem 286: 16606-16614.
50. Alla V, Kowtharapu BS, Engelmann D, Emmrich S, Schmitz U, et al. (2012) E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry. Cell Cycle 11: 3067-3078.